Published Date: 22 Oct 2025
Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the main causes of cancer-related mortality. Precisely predicting whether ...
Read Full News1.
The most precise research tools for the deadliest blood cancer have been developed.
2.
FDA Expands Use of T-DXd in Early HER2+ Breast Cancer
3.
What does it mean for Biden's prostate cancer to be 'aggressive'? A urologic surgeon explains
4.
Brain cancer: a Q&A session.
5.
An ancient signaling pathway and 20 years of research offer hope for rare cancer
1.
Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being
2.
Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care
3.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
4.
RDW-CV vs. MCV: Knowing the Difference Can Help You Better Understand Your Health
5.
All You Need To Know About Cancer Antigen 27-29: Causes, Symptoms & Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Lung Cancer Congress®
3.
Genito-Urinary Oncology Summit 2026
4.
Future NRG Oncology Meeting
5.
ISMB 2026 (Intelligent Systems for Molecular Biology)
1.
Navigating the Complexities of Ph Negative ALL - Part XVI
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
3.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
4.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation